Therefore, we performed the current study to examine the ability of physiologically relevant PON lactonase activity to predict adverse clinical outcomes in the CKD setting and to assess the relationship between the circulating PON-1 protein, PON lactonase activity, and the adverse clinical outcomes in this setting. The gene discussed is PON1; the disease is chronic kidney disease.